52
Views
22
CrossRef citations to date
0
Altmetric
Original Article

HLA and H2 Class II Transgenic Mouse Models to Study Susceptibility and Protection in Autoimmune Thyroid Disease

, , &
Pages 397-404 | Published online: 07 Jul 2009

References

  • Vladutiu, A.O. and Rose, N.R. (1971) "Autoimmune murine thyroiditis: relation to histocompatibility (H-2) type", Science 174, 1137–1139.
  • Kong, Y.M. (1986) "The mouse model of autoimmune thyroid disease", In: McGregor, A.M., ed, Immunology of Endocrine Diseases (MTP Press Limited, Lancaster, UK), pp 1–24.
  • Kong, Y.M. (1999) "Experimental models for autoinrunune thyroid disease: recent developments", In: Volpe, R., ed, Contemporary Endocrinology: Autoimmune Endocrinopathies (Humana Press Inc., Totowa, NJ), pp 91–111.
  • Kong, Y.M., Lomo, L.C., Motte, R.W., Giraldo, A.A., Baisch, J., Strauss, G., Hammerling, G.J. and David, C.S. (1996) "HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene", J. Exp. Med. 184, 1167–1172.
  • Vaidya, B., Kendall-Taylor, P. and Pearce, S.H.S. (2002) "Genetics of endocrine disease: the genetics of autoimmune thyroid disease", J. Clin. Endocrinol. Metab. 87, 5385–5397.
  • Taneja, V. and David, C.S. (1999) "HLA class II transgenic mice as models of human diseases", Immunol. Rev. 169, 67–79.
  • Carayanniotis, G. and Rao, V.P. (1997) "Searching for pathogenic epitopes in thyroglobulin: parameters and caveats", Immunol. Today 18, 83–88.
  • Kong, Y.M., David, CS., Lomo, L.C., Fuller, BE., Motte, R.W. and Giraldo, A.A. (1997) "Role of mouse and human class 11 transgenes in susceptibility to and protection against mouse autoimmune thyroiditis", Immunogenetics 46, 312–317.
  • Wan, Q., Shah, R., McCormick, D.J., Lomo, L.C., Giraldo, A.A., David, C.S. and Kong, Y.M. (1999) "H2-E transgenic class 11-negative mice can distinguish self from nonself in susceptibility to heterologous thyroglobulins in autoimmune thyroiditis", Immuno-genetics 50, 22–30.
  • Flynn, J.C., Fuller, BE., Giraldo, A.A., Panos, IC., David, C.S. and Kong, Y.M. (2001) "Flexibility of TCR repertoire and permissiveness of HLA-DR3 molecules in experimental auto-immune thyroiditis in nonobese diabetic mice", J. Autoimmun. 17, 7–15.
  • Wan, Q., Shah, R., Panos, J.C., Giraldo, A.A., David, C.S. and Kong, Y.M. (2002) "HLA-DR, LA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible", Human Immunol. 63, 301–310.
  • Lomo, L.C., Zhang, F., McCormick, D.J., Giraldo, A.A., David, C.S. and Kong, Y.M. (1998) "Flexibility of the thyroiditogenic T cell repertoire for murine autoimmune thyroiditis in CD8-deficient ((2m — I—) and T cell receptor VIr congenic mice", Autoimmunity 27, 127–133.
  • Flynn, J.C., Wan, Q., Panos, IC., McCormick, D.J., Giraldo, A.A., David, C.S. and Kong, Y.M. (2002) "Coexpression of susceptible and resistant HLA class II transgenes in murine experimental autoimmune thyroiditis: DQ8 molecules downregulate DR3-mediated thyroiditis", J. Autoimmun. 18, 213–220.
  • Wan, Q., Motte, R.W., McCormick, D.J., Fuller, BE., Giraldo, A.A., David, C.S. and Kong, Y.M. (1997) "Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis: role of MHC class 11", Clin. Immunol. Immunopathol. 85, 187–194.
  • Fuller, BE., Giraldo, A.A., Motte, R.W., Wang, C., Nabozny, G.H., David, C.S. and Kong, Y.M. (1995) "T-cell receptor Vp gene usage in experimental autoimmune thyroiditis", Ann. N. Y Acad. Sci. 756, 450–452.
  • Kong, Y.M., McCormick, D.J., Wan, Q., Motte, R.W., Fuller, B.E., Giraldo, A.A. and David, C.S. (1995) "Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis: secondary role of iodination", J. Immunol. 155, 5847–5854.
  • Lomo, L.C., Motte, R.W., Giraldo, A.A., Nabozny, G.H., David, CS., Rimm, U. and Kong, Y.M. (1996) "V138.2 transgene expression interferes with development of experimental auto-immune thyroiditis in CBA k/q but not k/k mice", Cell. Immunol. 168, 297–301.
  • Fuller, BE., Giraldo, A.A., Motte, R.W., Nabozny, G.H., David, C.S. and Kong, Y.M. (1994) "Noninvolvement of V138+ T cells in murine thyroglobulin-induced experimental autoimmune thyroid-itis", Cell. Immunol. 159, 315–322.
  • Yan, Y, Panos, J.C., McCormick, D.J., Wan, Q., Giraldo, A.A., Brusic, V, David, C.S. and Kong, Y.M. (2001) "Characterization of a novel H2A-E± transgenic model susceptible to heterologous but not self thyroglobulin in autoimmune thyroiditis: thyroiditis transfer with V138+ T cells", Cell. Immunol. 212, 63–70.
  • Caturegli, P., Vidalain, P.O., Vail, M., Aguilera-Galaviz, L.A. and Rose, N.R. (1997) "Cloning and characterization of murine thyroglobulin cDNA", Clin. Immunol. Immunopathol. 85, 221–226.
  • Flynn, J.C., Wan, Q., Brusic, V, McCormick, D.J., Panos, J.C., Giraldo, A.A., David, C.S. and Kong, Y.M. (2001) "Coexpression of susceptible and resistant HLA class 11 molecules and identification of pathogenic peptides in HLA-DR3-transgenic, H2A-negative mouse strains in autoimmune thyroiditis", J. Endocrinol. Investig. 24(6), 60.
  • Yan, Y, McCormick, D.J., Brusic, V, Panos, J., Giraldo, A.A., David, C.S. and Kong, Y.M. (2002) "Pathogenicity of predicted T cell epitopes from human thyroglobulin in an H2A-E± transgenic model of autoimmune thyroiditis inducible only with heterologous thyroglobulin", J. Endocrinol. Investig. 25(7), 30.
  • Shimojo, N., Kohno, Y, Yamaguchi, K., Kikuoka, S., Hoshioka, A., Niimi, H., Hirai, A., Tamura, Y., Saito, Y, Kohn, L.D. and Tahara, K. (1996) "Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class 11 molecule", Proc. Natl Acad. Sci. USA 93, 11074–11079.
  • Kaithamana, S., Fan, J., Osuga, Y., Liang, S-G. and Prabhakar, B.S. (1999) "Induction of experimental autoimmune Graves' disease in BALB/c mice", J. Immunol. 163, 5157–5164.
  • Costagliola, S., Many, M-C., Denef, J-F., Pohlenz, J., Refetoff, S. and Vassart, G. (2000) "Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease", J. Clin. Investig. 105, 803–811.
  • Nagayama, Y, Kita-Furuyama, M., Ando, T., Nakao, K., Mizuguchi, H., Hayakawa, T., Eguchi, K. and Niwa, M. (2002) "A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor", J. Immunol. 168, 2789–2794.
  • Rao, P.V., Watson, RE, Weetman, AR, Carayanniotis, G. and Banga, J.P. (2003) "Contrasting activities of thyrotropin receptor antibodies in experimentl models of Graves' disease induced by injection of transfected fibroblasts or deoxyribonucleic acid vaccination", Endocrinology 144, 260–266.
  • Pichurin, P., Yan, X-M., Farilla, L., Guo, J., Chazenbalk, G.D., Rapoport, B. and McLachlan, S.M. (2001) "Naked TSH receptor DNA vaccination: a TH1 T cell response in which interferon-'y production, rather than antibody, dominates the immune response in mice", Endocrinology 142, 3530–3536.
  • Flynn, J.C., Rao, RV, Gora, M., Alsharabi, G., Wei, W., Giraldo, A.A., David, CS., Banga, J.P. and Kong, Y.M. (2003) "Graves' hyperthyroidism induced in HLA-DRB1*0301 (DR3) transgenic mice by immunization with thyrotropin receptor DNA", FASEB J. 17, C43. (Clin. Exp. Immunol., Submitted).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.